NCT04500626View on ClinicalTrials.gov

Hyperbaric Versus Normobaric Oxygen Therapy for COVID-19 Patients

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

April 15, 2021

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions
Covid19
Interventions
DRUG

Oxygen

Hyperbaric oxygen therapy delivered in a monoplace or multi-place chamber. Supervised by a hyperbaric oxygen therapy physician and a chamber operator.

Trial Locations (2)

K1Y4E9

NOT_YET_RECRUITING

The Ottawa Hospital, Ottawa

M1E 5E9

RECRUITING

Rouge Valley Hyperbaric Medical Centre, Scarborough Village

Sponsors
All Listed Sponsors
collaborator

Climate Foundation

UNKNOWN

lead

Ottawa Hospital Research Institute

OTHER